Given that the anchorage-independency bestows upon tumor cells the potential to colonize distant organs and form malignant lesions [38], anti-GPC1 mAb treatment is likely to be effective against tumorigenesis and cancer metastasis. The gene discussed is GPC1; the disease is neoplasm.